世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000038896

びまん性大細胞型B細胞リンパ腫(DLBCL)治療薬の世界市場(2024-2028)

TechNavio

Global diffuse large B-Cell lymphoma (DLBCL) therapeutics market 2024-2028

発刊日 2024/05/20

言語英語

体裁PDF/177ページ

ライセンス/価格177ページ

0000038896

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

びまん性大細胞型B細胞リンパ腫(DLBCL)治療薬市場は2023年から2028年に22億4,980万米ドル、予測期間中のCAGRは8.09%で成長すると予測されます。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場は、高齢者人口の増加、DLBCLの罹患率の増加、再発または難治性のDLBCL患者に対する治療薬の承認の増加によって牽引されています。

調査範囲

  • 市場セグメント
    ➣ 用途別
      ◇ 病院薬局
      ◇ 小売薬局
      ◇ オンライン薬局
      ◇ その他
    ➣ 製品別
      ◇ 小分子
      ◇ 生物製剤
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ 世界のその他の地域

この調査では、技術の進歩が今後数年間のびまん性大細胞型B細胞リンパ腫(DLBCL)治療薬市場成長を牽引する主要因の1つであるとしています。また、患者支援プログラムの増加や戦略的提携は、市場の大きな需要につながります。

びまん性大細胞型B細胞リンパ腫(DLBCL)治療薬市場に関するレポートは、次の分野をカバーしています。

  • びまん性大細胞型B細胞リンパ腫(DLBCL)治療薬市場の規模
  • びまん性大細胞型B細胞リンパ腫(DLBCL)治療薬市場の予測
  • びまん性大細胞型B細胞リンパ腫(DLBCL)治療薬市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。

  • 調査企業
    ➣ AbbVie Inc.
    ➣ ADC Therapeutics SA
    ➣ Amgen Inc.
    ➣ Bayer AG
    ➣ BeiGene Ltd.
    ➣ Bristol Myers Squibb Co.
    ➣ Celltrion Healthcare Co. Ltd.
    ➣ CTI BioPharma Corp.
    ➣ Erytech Pharma SA
    ➣ F. Hoffmann La Roche Ltd.
    ➣ Gilead Sciences Inc.
    ➣ GlaxoSmithKline Plc
    ➣ Johnson and Johnson Services Inc.
    ➣ Merck and Co. Inc.
    ➣ Novartis AG, Pfizer Inc.
    ➣ Seagen Inc., Spectrum Pharmaceuticals Inc.
    ➣ 武田製薬工業(Takeda Pharmaceutical Co. Ltd.)
    ➣ Teva Pharmaceutical Industries Ltd.

また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market 2018 - 2022
Historic Market Size - Data Table on Global Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market 2018 - 2022 ($ million)
4.2 Application segment analysis 2018 - 2022
Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.3 Product segment analysis 2018 - 2022
Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application
6.1 Market segments
Chart on Application - Market share 2023-2028 (%)
Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
6.3 Hospital pharmacy - Market size and forecast 2023-2028
Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
6.4 Retail pharmacy - Market size and forecast 2023-2028
Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
6.5 Online pharmacy - Market size and forecast 2023-2028
Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million)
Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million)
Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
6.6 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Application
Market opportunity by Application ($ million)
Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Product
7.1 Market segments
Chart on Product - Market share 2023-2028 (%)
Data Table on Product - Market share 2023-2028 (%)
7.2 Comparison by Product
Chart on Comparison by Product
Data Table on Comparison by Product
7.3 Small molecules - Market size and forecast 2023-2028
Chart on Small molecules - Market size and forecast 2023-2028 ($ million)
Data Table on Small molecules - Market size and forecast 2023-2028 ($ million)
Chart on Small molecules - Year-over-year growth 2023-2028 (%)
Data Table on Small molecules - Year-over-year growth 2023-2028 (%)
7.4 Biologics - Market size and forecast 2023-2028
Chart on Biologics - Market size and forecast 2023-2028 ($ million)
Data Table on Biologics - Market size and forecast 2023-2028 ($ million)
Chart on Biologics - Year-over-year growth 2023-2028 (%)
Data Table on Biologics - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Product
Market opportunity by Product ($ million)
Data Table on Market opportunity by Product ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape2023-2028 (%)
Data Table on Market share By Geographical Landscape2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Market opportunity By Geographical Landscape($ million)
Data Tables on Market opportunity By Geographical Landscape($ million)

10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business

12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
12.4 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
12.5 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
12.6 BeiGene Ltd.
BeiGene Ltd. - Overview
BeiGene Ltd. - Business segments
BeiGene Ltd. - Key offerings
BeiGene Ltd. - Segment focus
12.7 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
12.8 Celltrion Healthcare Co. Ltd.
Celltrion Healthcare Co. Ltd. - Overview
Celltrion Healthcare Co. Ltd. - Product / Service
Celltrion Healthcare Co. Ltd. - Key offerings
12.9 CTI BioPharma Corp.
CTI BioPharma Corp. - Overview
CTI BioPharma Corp. - Product / Service
CTI BioPharma Corp. - Key offerings
12.10 Erytech Pharma SA
Erytech Pharma SA - Overview
Erytech Pharma SA - Product / Service
Erytech Pharma SA - Key offerings
12.11 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
12.12 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
12.13 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
12.14 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
12.15 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.16 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
12.17 Spectrum Pharmaceuticals Inc.
Spectrum Pharmaceuticals Inc. - Overview
Spectrum Pharmaceuticals Inc. - Product / Service
Spectrum Pharmaceuticals Inc. - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Application Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Application - Market share 2023-2028 (%)
Exhibits33: Data Table on Application - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Application
Exhibits35: Data Table on Comparison by Application
Exhibits36: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits44: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits45: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits46: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits47: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits48: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits49: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits50: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits52: Market opportunity by Application ($ million)
Exhibits53: Data Table on Market opportunity by Application ($ million)
Exhibits54: Chart on Product - Market share 2023-2028 (%)
Exhibits55: Data Table on Product - Market share 2023-2028 (%)
Exhibits56: Chart on Comparison by Product
Exhibits57: Data Table on Comparison by Product
Exhibits58: Chart on Small molecules - Market size and forecast 2023-2028 ($ million)
Exhibits59: Data Table on Small molecules - Market size and forecast 2023-2028 ($ million)
Exhibits60: Chart on Small molecules - Year-over-year growth 2023-2028 (%)
Exhibits61: Data Table on Small molecules - Year-over-year growth 2023-2028 (%)
Exhibits62: Chart on Biologics - Market size and forecast 2023-2028 ($ million)
Exhibits63: Data Table on Biologics - Market size and forecast 2023-2028 ($ million)
Exhibits64: Chart on Biologics - Year-over-year growth 2023-2028 (%)
Exhibits65: Data Table on Biologics - Year-over-year growth 2023-2028 (%)
Exhibits66: Market opportunity by Product ($ million)
Exhibits67: Data Table on Market opportunity by Product ($ million)
Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits69: Chart on Market share By Geographical Landscape2023-2028 (%)
Exhibits70: Data Table on Market share By Geographical Landscape2023-2028 (%)
Exhibits71: Chart on Geographic comparison
Exhibits72: Data Table on Geographic comparison
Exhibits73: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits102: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits103: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits105: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits106: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits107: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits108: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits109: Market opportunity By Geographical Landscape($ million)
Exhibits110: Data Tables on Market opportunity By Geographical Landscape($ million)
Exhibits111: Impact of drivers and challenges in 2023 and 2028
Exhibits112: Overview on criticality of inputs and factors of differentiation
Exhibits113: Overview on factors of disruption
Exhibits114: Impact of key risks on business
Exhibits115: Companies covered
Exhibits116: Matrix on companies position and classification
Exhibits117: AbbVie Inc. - Overview
Exhibits118: AbbVie Inc. - Product / Service
Exhibits119: AbbVie Inc. - Key news
Exhibits120: AbbVie Inc. - Key offerings
Exhibits121: Amgen Inc. - Overview
Exhibits122: Amgen Inc. - Product / Service
Exhibits123: Amgen Inc. - Key news
Exhibits124: Amgen Inc. - Key offerings
Exhibits125: Bayer AG - Overview
Exhibits126: Bayer AG - Business segments
Exhibits127: Bayer AG - Key news
Exhibits128: Bayer AG - Key offerings
Exhibits129: Bayer AG - Segment focus
Exhibits130: BeiGene Ltd. - Overview
Exhibits131: BeiGene Ltd. - Business segments
Exhibits132: BeiGene Ltd. - Key offerings
Exhibits133: BeiGene Ltd. - Segment focus
Exhibits134: Bristol Myers Squibb Co. - Overview
Exhibits135: Bristol Myers Squibb Co. - Product / Service
Exhibits136: Bristol Myers Squibb Co. - Key news
Exhibits137: Bristol Myers Squibb Co. - Key offerings
Exhibits138: Celltrion Healthcare Co. Ltd. - Overview
Exhibits139: Celltrion Healthcare Co. Ltd. - Product / Service
Exhibits140: Celltrion Healthcare Co. Ltd. - Key offerings
Exhibits141: CTI BioPharma Corp. - Overview
Exhibits142: CTI BioPharma Corp. - Product / Service
Exhibits143: CTI BioPharma Corp. - Key offerings
Exhibits144: Erytech Pharma SA - Overview
Exhibits145: Erytech Pharma SA - Product / Service
Exhibits146: Erytech Pharma SA - Key offerings
Exhibits147: F. Hoffmann La Roche Ltd. - Overview
Exhibits148: F. Hoffmann La Roche Ltd. - Business segments
Exhibits149: F. Hoffmann La Roche Ltd. - Key news
Exhibits150: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits151: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits152: GlaxoSmithKline Plc - Overview
Exhibits153: GlaxoSmithKline Plc - Business segments
Exhibits154: GlaxoSmithKline Plc - Key news
Exhibits155: GlaxoSmithKline Plc - Key offerings
Exhibits156: GlaxoSmithKline Plc - Segment focus
Exhibits157: Johnson and Johnson Services Inc. - Overview
Exhibits158: Johnson and Johnson Services Inc. - Business segments
Exhibits159: Johnson and Johnson Services Inc. - Key news
Exhibits160: Johnson and Johnson Services Inc. - Key offerings
Exhibits161: Johnson and Johnson Services Inc. - Segment focus
Exhibits162: Merck and Co. Inc. - Overview
Exhibits163: Merck and Co. Inc. - Business segments
Exhibits164: Merck and Co. Inc. - Key news
Exhibits165: Merck and Co. Inc. - Key offerings
Exhibits166: Merck and Co. Inc. - Segment focus
Exhibits167: Novartis AG - Overview
Exhibits168: Novartis AG - Business segments
Exhibits169: Novartis AG - Key news
Exhibits170: Novartis AG - Key offerings
Exhibits171: Novartis AG - Segment focus
Exhibits172: Pfizer Inc. - Overview
Exhibits173: Pfizer Inc. - Product / Service
Exhibits174: Pfizer Inc. - Key news
Exhibits175: Pfizer Inc. - Key offerings
Exhibits176: Spectrum Pharmaceuticals Inc. - Overview
Exhibits177: Spectrum Pharmaceuticals Inc. - Product / Service
Exhibits178: Spectrum Pharmaceuticals Inc. - Key offerings
Exhibits179: Inclusions checklist
Exhibits180: Exclusions checklist
Exhibits181: Currency conversion rates for US$
Exhibits182: Research methodology
Exhibits183: Information sources
Exhibits184: Data validation
Exhibits185: Validation techniques employed for market sizing
Exhibits186: Data synthesis
Exhibits187: 360 degree market analysis
Exhibits188: List of abbreviations

この商品のレポートナンバー

0000038896

TOP